Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fox Chase Temple Urologic Institute is a specialized clinical and research entity formed through the integration of urology services from Fox Chase Cancer Center and Temple Health. Based in Philadelphia, the institute provides comprehensive care for a wide range of urologic conditions, with a particular emphasis on urologic oncology. It is a leader in robotic-assisted surgery and minimally invasive techniques for treating cancers of the prostate, kidney, and bladder. As part of an NCI-designated Comprehensive Cancer Center, the institute offers patients access to a broad array of innovative clinical trials and advanced diagnostic tools. The multidisciplinary team includes world-renowned surgeons, oncologists, and researchers dedicated to improving patient outcomes through personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fox Chase Temple Urologic Institute.